Use of Lecithin As an Antistatic Agent in Nonconductive Crystallization Slurries for Isolating Pure Active Pharmaceutical Ingredients

被引:3
|
作者
Lee, Ivan Hao [1 ]
机构
[1] Merck & Co Inc, Chem Proc Dev & Commercializat, Rahway, NJ 07065 USA
关键词
SURFACTANT; ALVEOLAR;
D O I
10.1021/op4001065
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Static buildup in glass-lined processing train during pure API crystallizations in organic solvents can result in costly glass damage to the vessel internals, and presents a potential safety risk of fire or explosion. The propensity for static buildup is directly related to the conductivity of the solvent system and is especially high for nonpolar organic solvents such as toluene and heptane. Lecithin is a zwitterionic organic surfactant commonly used in the food and pharmaceutical industry. Lecithin has been proposed as an antistatic agent due to its relatively high solubility in nonpolar organic solvents, as well as its charge carrying capabilities when dissolved. Because lecithin is routinely used in the pharmaceutical industry including in final drug product formulations, it has the advantage of having a reduced regulatory hurdle for implementation during API processing relative to other commercial antistatic agents that do not have precedence for pharmaceutical applications. Experimental results show that addition of lecithin at ppm levels is sufficient to increase solution and pure API slurry conductivity to above an acceptable threshold that reduces the risk of static charge buildup with a linear relationship between conductivity and lecithin concentration demonstrated. Noteworthy is the observation that the amount of lecithin required is related to the surface area of the API solids, as sufficient lecithin must be added to coat the solid surface with approximately monolayer coverage before the excess lecithin is solvated and electrically active in solution. Finally, head-to-head comparison studies with and without lecithin for three API compounds have shown that lecithin does not significantly impact the crystallization process or the physical properties of the API generated.
引用
收藏
页码:1330 / 1334
页数:5
相关论文
共 50 条
  • [21] Technoeconomic Optimization of Continuous Crystallization for Three Active Pharmaceutical Ingredients: Cyclosporine, Paracetamol, and Aliskiren
    Diab, Samir
    Gerogiorgis, Dimitrios, I
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2018, 57 (29) : 9489 - 9499
  • [22] On Secondary Patenting of Organic Compounds Suitable for use as Active Pharmaceutical Ingredients
    Goizman, M. S.
    Shimanovskii, N. L.
    Zotova, O. A.
    Ryzhkov, I. O.
    Popova, A. O.
    Chernobrovkin, M. G.
    Korlyukov, A. A.
    Suponitskii, K. Yu.
    Sinel'nikov, A. V.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2019, 53 (09) : 876 - 882
  • [23] On Secondary Patenting of Organic Compounds Suitable for use as Active Pharmaceutical Ingredients
    M. S. Goizman
    N. L. Shimanovskii
    O. A. Zotova
    I. O. Ryzhkov
    A. O. Popova
    M. G. Chernobrovkin
    A. A. Korlyukov
    K. Yu. Suponitskii
    A. V. Sinel’nikov
    Pharmaceutical Chemistry Journal, 2019, 53 : 876 - 882
  • [24] Use of prediction methods to estimate true density of active pharmaceutical ingredients
    Cao, Xiaoping
    Leyva, Norma
    Anderson, Stephen R.
    Hancock, Bruno C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) : 231 - 237
  • [25] An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine
    Baghel, Shrawan
    Cathcart, Helen
    Redington, Wynette
    O'Reilly, Niall J.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 104 : 59 - 71
  • [26] Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients
    Watson, Oliver L.
    Jonuzaj, Suela
    McGinty, John
    Sefcik, Jan
    Galindo, Amparo
    Jackson, George
    Adjiman, Claire S.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2021, 25 (05) : 1123 - 1142
  • [27] Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients
    Watson, Oliver L.
    Jonuzaj, Suela
    McGinty, John
    Sefcik, Jan
    Galindo, Amparo
    Jackson, George
    Adjiman, Claire S.
    Organic Process Research and Development, 2021, 25 (05): : 1123 - 1142
  • [28] Model-Based Optimization of Cooling Crystallization of Active Pharmaceutical Ingredients Undergoing Thermal Degradation
    Pal, Kanjakha
    Yang, Yang
    Nagy, Zoltan K.
    CRYSTAL GROWTH & DESIGN, 2019, 19 (06) : 3417 - 3429
  • [29] Incipient crystallization of active pharmaceutical ingredients in complex matrices detected by second harmonic generation microscopy
    Simpson, Garth J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [30] Olefin metathesis: a versatile synthetic tool for use in preparation of Active Pharmaceutical Ingredients
    Olszewski, Tomasz K.
    Figlus, Marek
    Bieniek, Michal
    CHIMICA OGGI-CHEMISTRY TODAY, 2014, 32 (05) : 22 - +